Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability
- PMID: 29232521
- DOI: 10.1021/acs.molpharmaceut.7b00761
Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability
Abstract
Neuropilin-1 (NRP1), which functions as a coreceptor for vascular endothelial growth factor (VEGF) and is implicated in vascular permeability and tumorigenesis, has been targeted by peptides that specifically bind to the VEGF-binding region on NRP1. Like natural VEGF ligands, all known peptides with NRP1-binding activity bind only through a carboxy (C)-terminal R/K-x-x-R/K sequence motif (x stands for any amino acids); this strict requirement is called the C-end rule (CendR). Here, we report immunoglobulin Fc-fused NRP1-specific peptides deviating from CendR. We screened a yeast surface-displayed Fc-fused non-CendR peptide library against NRP1 and isolated Fc-V12, wherein V12 peptide comprising 12 amino acids has a PPRV sequence at its C-terminal end. Although Fc-V12 lacked the CendR motif, it showed selective binding to the VEGF-binding region of NRP1 and triggered cellular internalization of NRP1, which resulted in enhanced extravasation into tumor tissues and tumor tissue penetration of the Fc-fused peptide along with the coinjected chemical drug in tumor-bearing mice. Through a saturation mutagenesis study, we identified that the Val residue at the C-terminus of Fc-V12 is crucial for NRP1 binding. We further improved NRP1 affinity of Fc-V12 (KD = ∼761 nM) through directed evolution of the upstream sequence of PPRV to obtain Fc-V12-33 (KD = ∼17.4 nM), which exhibited enhanced NRP1-mediated vascular permeability as compared with Fc-V12. Our results provide functional Fc-fused non-CendR peptides, which bind to the VEGF-binding region of NRP1 and enhance vascular permeability, expanding the sequence space of NRP1-targeting peptides.
Keywords: C-end rule; neuropilin-1; peptide engineering; vascular permeability; yeast surface display.
Similar articles
-
Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis.J Control Release. 2015 Oct 28;216:56-68. doi: 10.1016/j.jconrel.2015.08.016. Epub 2015 Aug 8. J Control Release. 2015. PMID: 26260451
-
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration.Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16157-62. doi: 10.1073/pnas.0908201106. Epub 2009 Sep 2. Proc Natl Acad Sci U S A. 2009. PMID: 19805273 Free PMC article.
-
Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation.Sci Signal. 2016 Apr 26;9(425):ra42. doi: 10.1126/scisignal.aad3812. Sci Signal. 2016. PMID: 27117252
-
Neuropilin regulation of angiogenesis, arteriogenesis, and vascular permeability.Microcirculation. 2014 May;21(4):315-23. doi: 10.1111/micc.12124. Microcirculation. 2014. PMID: 24521511 Free PMC article. Review.
-
Neuropilin-1 enforces extracellular matrix signalling via ABL1 to promote angiogenesis.Biochem Soc Trans. 2014 Oct;42(5):1429-34. doi: 10.1042/BST20140141. Biochem Soc Trans. 2014. PMID: 25233427 Review.
Cited by
-
Characterization of peptide binding to the SARS-CoV-2 host factor neuropilin.Heliyon. 2021 Oct;7(10):e08251. doi: 10.1016/j.heliyon.2021.e08251. Epub 2021 Oct 23. Heliyon. 2021. PMID: 34722943 Free PMC article.
-
Neuropilins in the Context of Tumor Vasculature.Int J Mol Sci. 2019 Feb 1;20(3):639. doi: 10.3390/ijms20030639. Int J Mol Sci. 2019. PMID: 30717262 Free PMC article. Review.
-
Yeast Mating as a Tool for Highly Effective Discovery and Engineering of Antibodies via Display Methodologies.Methods Mol Biol. 2022;2491:313-333. doi: 10.1007/978-1-0716-2285-8_17. Methods Mol Biol. 2022. PMID: 35482198
-
Engineering of anti-human interleukin-4 receptor alpha antibodies with potent antagonistic activity.Sci Rep. 2019 May 23;9(1):7772. doi: 10.1038/s41598-019-44253-9. Sci Rep. 2019. PMID: 31123339 Free PMC article.
-
Expanding the Therapeutic Window of EGFR-Targeted PE24 Immunotoxin for EGFR-Overexpressing Cancers by Tailoring the EGFR Binding Affinity.Int J Mol Sci. 2022 Dec 13;23(24):15820. doi: 10.3390/ijms232415820. Int J Mol Sci. 2022. PMID: 36555466 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous